Cystic Fibrosis Foundation

Funding Organization

Awards Grant

  • (KBoost) Pharmacometric Approaches to Precision Optimization of Ivacaftor Response
  • A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
  • A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study) (PROMISE-OB-18)
  • A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study) (PROMISE-OB-18)
  • A Prospective Study to Evaluate Effects of Corrected CFTR Function (BEGIN)
  • A Reporter System to Monitor the Association of eRF1 and eRF3
  • A Two-Part Multicenter Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
  • Abnormal Mucus as the Initiating Factor in P. Aeruginosa Infection in CF
  • Amino Acids Incorporated at CFTR Nonsense Mutations During Readthrough
  • Assessing Response of B-Adrenergic Sweat Secretion in Patients with R117H Mutations Following Treatment with Ivacaftor (GOALe2 Ancillary)
  • Award for a Mental Health Coordinator
  • Award for a Physical Therapist
  • BEGIN Sub-study – Continuous Glucose Monitoring in Healthy Children
  • Baby and Early Childhood Endocrine Factors and Growth in Cystic Fibrosis (BEGIN) Study
  • Brevenal Effect on Mucociliary Clearance for Treatment of CF Mucus
  • CF Center in Chile, Pilot and Feasibility Program
  • CFF Clinical Fellowship
  • CFTR Functional Restoration by Antisense Oligonucleotides
  • CFTR Protein Core
  • CFTR Protein Core
  • CFTR Structural Energetics: Domain Communication, Ligand Binding Response
  • CFTR Structural Energetics: Domain Communication, Ligand Binding Response
  • CFTR and the CF Rat Islet: A Novel Model for the Study of CFRD
  • Characterization of Novel Translational Readthrough Agents Discovered by High Throughput Screening
  • Confirmation-Dependent Trapping and Small Molecule Click Mapping of CFTR
  • Consultant for Translational Science
  • Consultant for Translational Science
  • Core Center for Measurements of Mucus and Mucociliary Clearance
  • Correction of CFTR mRNA Using Trans-acting Ribozymes
  • Crystallization and Structure Determination of Full-Length CFTR Protein
  • Cystic Fibrosis Lung Transplant Transition LLC2
  • Cystic Fibrosis Training Network: Latin America
  • Cytochrome p450 Enzymes In Metabolism And Efficacy Of Ivacaftor
  • Development of Hyperinflammation in the Cystic Fibrosis Rat
  • Dysbiosis of the Sinus Microbiota in Chronic Rhinosinusitis
  • Early Recognition and Intervention for Acute Pulmonary Exacerbation in CF
  • Effect of PAAG Treatment on CF Related Pseudomonas Infected Respiratory Epithelium
  • Evaluation of Approved Drug Libraries for Translational Readthrough Activity
  • Exacerbation of Influenza Secondary Infections in Cystic Fibrosis
  • Expression and Purification of CFTR Domain Constructs
  • Finding and Integrating Pharma and Nutrition Linked Genomic Variation in CF
  • First Year Clinical Fellowship
  • First and Second Year Clinical Fellowship
  • First and Second Year Clinical Fellowship
  • First/Second Year Clinical Fellowship
  • G551D Observational Study (GOAL-OB-11)
  • Genetic Analysis of X-mutation Read Through: Targets and Mechanisms
  • Impact of Host Response on Antimicrobial Susceptibility in Cystic Fibrosis
  • Implementation Of The Depression And Anxiety Guidelines Award For A Mental Health Coordinator
  • Implementation of the Depression and Anxiety Guideline: Award for a Mental Health Coordinator
  • Implications of Cross-Protease Dysregulation in CF
  • Increasing CFTR Expression by NMD Attenuation
  • Innovative Solutions Toward a 3D CFTR Structure
  • Investigating Nonsense-Mediated mRNA Decay as a Therapeutic Target
  • Making iPSCs a Reliable Model for Cystic Fibrosis Research
  • Mechanism of Aberrant Mucus Adhesion and Stasis in the CF Airways
  • Mechanisms of and Therapies for Abnormal Mucus Adhesion and Clearance in CF
  • Mechanisms of and Therapies for Abnormal Mucus Adhesion and Clearance in CF
  • Mechanistic Link Between Rescue of CFTR Mediated Anion Transport, Airway Surface Liquid Regulation, and Mucociliary Transport by CFTR Modulators
  • MiR-145 Mediated TGF-Beta Pathobiology in CF
  • Myofibroblast Differentiation in Cystic Fibrosis
  • Nasal Epithelial Cells as an Outcome Tool for Individualized CFTR Therapies
  • Novel Approaches to CFTR Modulator Mechanism in Cystic Fibrosis
  • Opportunistic Infections in Cystic Fibrosis
  • Optimization of the Alabama CF Newborn Screening Program
  • PROMISE-OB-18
  • Pediatric Cystic Fibrosis Center for Care, Teaching and Research
  • Pediatric Physical Therapist Award
  • Physical Therapist - UAB Adult CF Clinic
  • Potential Difference Measures Core for Advancing CFTR Therapeutics
  • Recombinant CFTR: Cooperativity and Structural Domains
  • Research Development Program
  • Research Development Program - Component II
  • Restoration of the CFTR Function by Splicing Modulation
  • Ribosomal Perturbation to Increase Functional Expression of F508del-CFTR
  • Role of Arginine-933 in CFTR Folding, Gating and Potentiator Drug Binding
  • Second Year Clinical Fellowship
  • Stabilized CFTR for Elucidating Biophysical & Structural Characteristics
  • Stenotrophomonas Maltophilia in Cystic Fibrosis
  • Structure, Mechanisms and Function of CFTR
  • Success with Therapies Research Consortium
  • Success with Therapies Research Consortium
  • Success with Therapies Research Consortium
  • Success with Therapies Research Consortium: UAB Site
  • Success with Therapies Research Consortium: UAB Site
  • Sweat Gland Culture Techniques for the Study of Cystic Fibrosis
  • Synonymous Single Nucleotide Polymorphisms (sSNP) and CFTR Function
  • TDN Additional Research Coordinator
  • TDN Additional Research Coordinator
  • TDN Additional Research Coordinator (ARC)
  • TDN Additional Research Coordinator (ARC)
  • TDN Additional Research Coordinator (ARC)
  • The 2015 TDN Spring Meeting
  • The CF Rat as an In Vivo Model of Airway Infection
  • The CXCL 10/CXCR3 Axis in CF-Related Fungal Exposure
  • The Mechanisms Underlying the Muco-Inflammatory Cycle in the CF Lung
  • The Mucociliary Clearance Defect of the Cystic Fibrosis Rat
  • The Mucociliary Clearance Defect of the Cystic Fibrosis Rat
  • The Role of FGF Receptor Signaling in Cystic Fibrosis
  • The Tetrahelix Bundle in CFTR Gating: CF Mutations and Potentiator Rescue
  • The Tetrahelix Bundle in CFTR Gating: CF Mutations and Potentiator Rescue
  • Therapeutic Development Center - UAB Center for CFTR Detection
  • Training and Equipment for the MBW sub-study of the PROSPECT Study.
  • Transformative Integrated Model for Continuous CF Care
  • Translational Therapeutic Development Center
  • UAB Center for CFTR Detection
  • UAB Cystic Fibrosis Center For Care Teaching And Research (Adult)
  • UAB Cystic Fibrosis Center for Care, Teaching and Research
  • UAB Cystic Fibrosis Center for Care, Teaching and Research
  • UAB Cystic Fibrosis Center for Care, Teaching and Research
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research (Adult)
  • UAB Cystic Fibrosis Therapeutic Development Network Center for CFTR Detection
  • UAB Cystic Fibrosis Translational Development Center
  • UAB Cystic Fibrosis Translational Therapeutic Development Center
  • UAB Research Development Program Component II - Overall Program
  • UAB Research and Development Program
  • UAB Therapeutic Development Network Center
  • Using Chamber Studies to Characterize CFTR Modulators
  • miR-145 Target Site Blockade to Amplify CFTR Correction